Adagio Medical Holdings, INC S-1 registration statements

Adagio Medical Holdings updates its S-1 registration statement to facilitate the resale of up to 67,963,695 shares of common stock by selling stockholders.

Adagio Medical Holdings updates its S-1 registration statement to reflect executive compensation for the fiscal year ended December 31, 2024, with no additional securities being registered.

Adagio Medical Holdings seeks to register the resale of up to 67.9 million common shares by existing stockholders, including shares from PIPE investors, convertible noteholders, and the Sponsor.

Adagio Medical Holdings seeks to register the resale of shares by selling stockholders following its recent business combination, involving convertible notes and warrants.

Adagio Medical Holdings files for potential sale of up to 8,505,387 shares of common stock through a preliminary prospectus.

Adagio Medical Holdings seeks to register the resale of up to 32.9 million shares of its common stock by existing stockholders.